Identification of a Plasma Proteomic Signature for Lung Cancer

CompletedOBSERVATIONAL
Enrollment

475

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Precancerous ConditionsCarcinoma
Trial Locations (12)

17822

Geisinger Medical Center, Danville

21204

Greater Baltimore Medical Center, Baltimore

33136

University of Miami - Sylvester Comprehensive Cancer Center, Miami

36207

North East Alabama Regional Medical Center, Anniston

45267

University of Cincinnati, Cincinnati

48202

Henry Ford Hospital, Detroit

55901

Mayo Clinic, Rochester

75230

Cardiopulmonary Research Science and Technology Institute, Dallas

84107

Intermountain Healthcare, Murray

94115

Kaiser Permanente Northern California, San Francisco

98101

Group Health Research Institute, Seattle

01805

Lahey Hospital & Medical Center, Burlington

Sponsors
All Listed Sponsors
lead

Integrated Diagnostics

INDUSTRY